Notice: Constant automattic\jetpack\extensions\social_previews\FEATURE_NAME already defined in /home2/theprkho/public_html/thepharmatimes.in/wp-content/plugins/jetpack/extensions/blocks/social-previews/social-previews.php on line 14
Home - The Pharma Times | Pharma & Health Care News Portal
Saturday, April 27, 2024

Pheal joins The Indian Association of Physiotherapists as a community partner...

Mumbai, February 14, 2023: International delegates representing the physiotherapy profession in their countries joined their Indian counterparts at the 60th annual National Conference of...

Biotechnology

IT & Software Support

Wipro GE Healthcare keen to make diagnostics affordable to all

Wipro GE Healthcare is keen to invest in technologies that are affordable to all.

Terri Bresenhem, President and Chief Executive, GE Healthcare, told reporters here on Wednesday that the company has not only been expanding its presence in India for over two decades now, but investing at least 30 per cent more in recent years. “The investment is both in terms of manpower and strengthening our research and development facility,” she said.

INDIA MANUFACTURE

“We are striving to make healthcare affordable to all. While most medical equipment companies that have established their presence here import close to 80 per cent of their equipment, our import component is less. At GE Healthcare, we design and manufacture 30 per cent of the equipment in India. We have a strong research team, high quality thinkers and innovators here,” she added.

Appointments

Awards

Amritha Gaddam, Founder & CEO, The Tribe Concepts, Bags BW Young Entrepreneur Award 2021

New Delhi, December 04, 2021: Amritha Gaddam, the Founder and CEO of The Tribe Concepts, a leading organic skincare brand, has been recognized in...
Cadila Pharma bags TISS LeapVault CLO awards in two categories

Cadila Pharma bags TISS LeapVault CLO awards in two categories

Ahmedabad, August 09, 2019: Cadila Pharmaceuticals bagged two TISS LeapVault CLO awards under the categories of 'Program for Sales Enablement' and 'Social Media Based...

Financial Results

Approvals

Lupin and Mylan Receive European Marketing Authorization for Nepexto®, Biosimilar Etanercept

Mumbai, June 04, 2020: Lupin Limited (Lupin) and Mylan N.V. (NASDAQ: MYL) today announced that the European Commission (EC) has granted marketing authorization for...

Clinical Trails

Phase III DECISION Trial of Nexavar® (sorafenib) Meets Primary Endpoint of Improving Progression-Free Survival...

Berlin, January 3, 2013 – Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. today announced that a Phase III trial of Nexavar® (sorafenib) tablets in patients with locally advanced or metastatic radioactive iodine (RAI)-refractory differentiated thyroid cancer has met its primary endpoint of a statistically significant improvement in progression-free survival. The study, called DECISION, evaluated the efficacy and safety of Nexavar compared to placebo. The safety and tolerability were generally consistent with the known profile of Nexavar. Detailed efficacy and safety analysis from this study are expected to be presented at an upcoming medical meeting. Effective treatment options are urgently needed for patients with RAI-refractory differentiated thyroid cancer,” said Dimitris Voliotis, MD, Vice President, Global Clinical Development Oncology, Bayer HealthCare. “We are pleased that the results of this study demonstrate that Nexavar may provide a treatment option for these patients.

Bulk Drug

Health Care

Alternative Medicine

Eye Care

Conjunctivitis at its peak by NIIMS

New Delhi, August 17, 2023: Conjunctivitis or pink eyes or red eyes is spreading at a fast rate. It is highly infectious and might...

ENTOD Pharmaceuticals Observes 38th National Eye Donation Fortnight Brighten Lives through Awareness

NEW DELHI,September  04 , 2023:  Entod Pharmaceuticals, a renowned pharmaceutical company in India, proudly announces a transformative event slated to run on the occasion...

Product News

Media Partners

Spotlight

Investments

Packaging

Latest News

The Challenges of motherhood

By  Dr.Ambuja Govindaraj, Consultant Obstetrics and Gynaecology, Columbia Asia Referral Hospital Yeshwanthpur Motherhood is season of realizing the deepest love you’ve ever known, a season...

Aster CMI Hospital Unveils Heart Failure Clinic and Daycare Centre

Bengaluru, December 18,  2023 :  Aster CMI Hospital today launched Heart Failure Clinic and expanded cardiac expertise with a one of its kind daycare Clinic...

Dental Care

Tips to maintain oral health!

By Dr.MS Prasad, Dental Surgeon, Columbia Asia Referral Hospital Yeshwanthpur It has been said that a person’s real happiness begins from the plate and is...

Hospital Management

Drug Discovery & Development

Developments in Bio-informatics will help drive discoveries

    • Training,  revamp  of  University  system,  Promote  Translation  of  Academicre search, Promoting Bio-Entrepreneurship will accelerate the industry growth

 

  • Synthetic  Biotechnology  has  tremendous  potential,  affordable  gene  sequencing can play a major role in the Food, Energy, fragrance & Flavors

Suppliers

Technology

Companies

Impact of Alcohol Consumption on Eye Health: Insights from a Senior...

Dr. Maramganty Vamshidhar, Sr.Cataract and Refractive Surgeon, Maxivision Eye Hospitals, Somajiguda, Hyderabad  With years of experience in treating various eye conditions, I am often asked...

​​Nurses, building bridges between doctors and patients

By Col Binu Sharma, Senior Vice President-Nursing Services, Columbia Asia Hospitals Pvt. Ltd Doctors are often considered no less than God for us, saving and...

Marketing

Our Partners

Machinery & Equipments